This was further supported by tumor weight analysis because the average tumor weight of the triple treatment group was lowest and was significantly different from two other groups by t tests (Fig. 7B, P < 0.05 vs mHAdLyp.sT and mHAdLyp.sT+anti-CTLA-4). This evidence concerns the gene CTLA4 and neoplasm.